Results

Total Results: 3,287 records

Showing results for "prevalence".
Users also searched for: communication

  1. www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2023qdr-data-sources.pdf
    December 01, 2023 - Therefore, estimates of incidence and prevalence of disease cannot be computed. … It includes information on the incidence, prevalence, morbidity, and mortality of this population, as
  2. digital.ahrq.gov/sites/default/files/docs/citation/cds-connect-year3-final-report-2019.pdf
    January 01, 2019 - consumers to help them self-manage the entire healthcare process. b.well’s mission is “to reduce the prevalence … agreement by b.well that the CDS was valuable and contributed to their overall mission to reduce the prevalence
  3. www.ahrq.gov/sites/default/files/wysiwyg/npsd/data/npsd-chartbook-2019.pdf
    January 01, 2019 - representative sample of patient safety concerns and cannot be used to calculate the actual incidence or prevalence … Hence, the event report data submitted to the NPSD cannot be used to calculate the actual incidence or prevalence
  4. www.ahrq.gov/sites/default/files/wysiwyg/evidencenow/building-capacity/en-bsc-interim-report-2.pdf
    July 01, 2024 - Applications (RFA) entitled Supporting Primary Care to Advance Cardiovascular Health in States with High Prevalence … HH4M and the ACC, HHOI, and THHN were initially selected in part because of the high prevalence of preventable
  5. www.uspreventiveservicestaskforce.org/home/getfilebytoken/_9KLmyQyMnoE3agQJsgNE-
    November 01, 2011 - age bracket for FDA-approved use of Hybrid Capture 2 as an adjunct to cytology (4, 5) and the reduced prevalence
  6. cds.ahrq.gov/sites/default/files/cds/artifact/1056/2024_CDS_Connect_IG_Statin_CVD_Patient_Facing_2.pdf
    January 01, 2024 - FCC has noted the prevalence of several risk factors in their patients for developing CVD—primarily
  7. www.ahrq.gov/research/findings/nhqrdr/2014chartbooks/womenhealth/womenh-slides.html
    March 01, 2020 - In 2013, asthma prevalence was 6.2% among males and 8.3% among females ( CDC ).
  8. www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/healthy-lifestyle-and-physical-activity-for-cvd-prevention-adults-without-known-risk-factors-behavioral-counseling
    July 26, 2022 - Because the prevalence and rate of these health outcomes are lower in lower-risk groups (by definition
  9. digital.ahrq.gov/sites/default/files/docs/citation/CommFocusedTechYoungAAWomenFinal.pdf
    March 01, 2017 - Prevalence of risk factors for adverse pregnancy outcomes during pregnancy and the preconception period
  10. www.ahrq.gov/sites/default/files/wysiwyg/research/findings/making-healthcare-safer/mhs3/care-transitions-1.pdf
    March 01, 2020 - The evidence in this section highlights intervention, prevalence, observational, and incidence studies
  11. www.ahrq.gov/sites/default/files/wysiwyg/patient-safety/highlights/ps-project-highlights-teamwork-leadership.pdf
    March 01, 2024 - Report Purpose: To conduct a 2-year, two-site prospective observational pilot study to measure the prevalence
  12. www.uspreventiveservicestaskforce.org/home/getfilebytoken/zVVRY6wa4Sgj-EJb3BRcVy
    November 01, 2013 - Medications for Risk Reduction of Primary Breast Cancer in Women: U.S. Preventive Services Task Force Recommendation Statement Virginia A. Moyer, MD, MPH, on behalf of the U.S. Preventive Services Task Force* Description: Update of the 2002 U.S. Preventive Services Task Force (USPSTF) recommendation on the use of medi…
  13. www.uspreventiveservicestaskforce.org/home/getfilebytoken/3Kwu7j_WfCFQSnSzqrDWwt
    June 20, 2019 - Medication Use to Reduce Risk of Breast Cancer: US Preventive Services Task Force Recommendation Statement Medication Use to Reduce Risk of Breast Cancer US Preventive Services Task Force Recommendation Statement US Preventive Services Task Force IMPORTANCE Breast cancer is the most common nonskin cancer among women…
  14. www.uspreventiveservicestaskforce.org/home/getfilebytoken/j69Hq5ALvzg74e-ngkzSep
    April 01, 2016 - Bleeding Risks With Aspirin Use for Primary Prevention in Adults: A Systematic Review for the USPSTF Bleeding Risks With Aspirin Use for Primary Prevention in Adults: A Systematic Review for the U.S. Preventive Services Task Force Evelyn P. Whitlock, MD, MPH; Brittany U. Burda, MPH; Selvi B. Williams, MD, MPH; Janell…
  15. digital.ahrq.gov/sites/default/files/docs/publication/uc1hs015196-crandall-final-report-2007.pdf
    January 01, 2007 - Rural Iowa Redesign of Care Delivery with EHR Functions - Grant Final Report Grant ID: 1UC1HS015196-0. 1 Grant Final Report Grant ID: 1UC1HS015196-0 Rural Iowa Redesign of Care Delivery with EHR Functions Inclusive Dates: 09/01/04 – 11/30/07 Principal Investigator: Donald K Cranda…
  16. www.ahrq.gov/sites/default/files/publications/files/prioritization-report_0.pdf
    January 01, 2020 - The comprehensive nature of APCD data allows: • Estimations of disease prevalence across a population
  17. www.uspreventiveservicestaskforce.org/home/getfilebytoken/zYdjLaTCTBVUwgJTnzpVXr
    May 08, 2018 - The high prevalence of undiagnosed prostate cancer at autopsy: implications for epidemiology and treatment
  18. cds.ahrq.gov/sites/default/files/cds/artifact/1056/2023_CDS_Connect_IG_Statin_CVD_Patient_Facing.pdf
    January 01, 2023 - FCC has noted the prevalence of several risk factors in their patients for developing CVD—primarily
  19. digital.ahrq.gov/sites/default/files/docs/publication/r21hs018811-krist-final-report-2012.pdf
    January 01, 2012 - by the USPSTF, with the exception of prostate cancer screening,11 which is included due to the high prevalence
  20. digital.ahrq.gov/sites/default/files/docs/page/NJ-EPAC%20Pilot%20Testing%20of%20Electronic%20Prescribing%20Standards_0.pdf
    April 01, 2008 - The time saving is robust, although the amount is depending on the prevalence of PA requirements and